ADVERTISEMENT
News
Debrichem - DEBx Medical
10/23/2024
https://clinicaltrials.gov/study/NCT06652360
DEBx Medical has initiated a 40-patient pilot RCT to examine the safety/efficacy of chemical debridement and curettage in treatment of venous and mixed etiology leg ulcers with primary outcome of percentage wound reduction at 12 weeks. Not yet recruiting; estimated completion is April 2025. clinicaltrials.gov